The recall impacts one lot of Diovan, which is Novartis' brand of valsartan, according to the agency.

The recall impacts one lot of Diovan, which is Novartis' brand of valsartan, according to the agency.

The FDA have urgently recalled a specific batch of blood pressure drugs as they may lead to 'temporary or medically reversible adverse health consequences'